Bhuvanesh Dave
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bhuvanesh Dave has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Jenny C. Chang
Houston Methodist Cancer Center, Houston, TX, USA
1 shared publication - Nicholas M Tan
Methodist Hospital Cancer Center, 6550 Fannin Street SM383, Houston, TX 77030, USA
1 shared publication - Vivek Mittal
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York
1 shared publication
Latest Publications
- Open Access
- 19 January 2012
- Published by Springer Nature in Breast Cancer Research
- Vol. 14 (1) , 202
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Breast cancer relapse, in a large number of patients, after initial response to standard of care therapy warrants development of novel therapies against recurrent and metastatic cancer. Cancer stem cells (CSCs), present in breast tumors while being intrinsically resistant to conventional therapy, have the ability to self renew and cause tumor recurrence. The residual tumors after therapy, with dramatic enrichment of the CSCs, have all the hallmarks of epithelial- mesenchymal transition (EMT). This review will focus on the link between EMT, CSCs and treatment resistance, since a better understanding of these interactions will allow us to effectively target the residual population after therapy.
- 19 January 2012
- Published by Springer Nature in Breast Cancer Research
- Vol. 14 (1) , 202
Open AccessEpithelial-mesenchymal transition, cancer stem cells and treatment resistance
Breast cancer relapse, in a large number of patients, after initial response to standard of care therapy warrants development of novel therapies against recurrent and metastatic cancer. Cancer stem cells (CSCs), present in breast tumors while being intrinsically resistant to conventional therapy, have the ability to self renew and cause tumor recurrence. The residual tumors after therapy, with dramatic enrichment of the CSCs, have all the hallmarks of epithelial- mesenchymal transition (EMT). This review will focus on the link between EMT, CSCs and treatment resistance, since a better understanding of these interactions will allow us to effectively target the residual population after therapy.